Global Cardiovascular Surgical Devices Market Trends & Forecast (2025–2033)

Cardiovascular Surgical Devices Market Size and Forecast 2025-2033

The cardiovascular surgical devices market is expected to grow from US$ 2.11 billion in 2024 to US$ 2.86 billion by 2033, at a compound annual growth rate of 3.45% from 2024 to 2033. This growth is due to the increasing prevalence of cardiovascular diseases, advancements in surgical technologies, and rising demand for minimally invasive procedures, thus playing a critical role in global cardiac healthcare.

The report Cardiovascular Surgical Devices Market & Forecast covers by Product Type (Beating Heart Surgery Systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposable), Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Others), End-User (Hospitals, Ambulatory Surgical Centers, Others), Country and Company 2025-2033.

Cardiovascular Surgical Devices Market Overview and Growth Drivers

Cardiovascular surgical devices are specialized medical tools designed to diagnose, treat, and manage heart and blood vessel conditions through surgical interventions. These devices are essential for addressing various cardiovascular diseases, including coronary artery disease, heart valve disorders, arrhythmias, and congenital heart defects. They play a critical role in procedures such as bypass surgery, valve repair or replacement, aneurysm repair, and heart transplantation.

Standard cardiovascular surgical devices include heart-lung machines, which ensure circulation and oxygenation of blood in open-heart surgeries; stents and grafts for restoring blocked or weakened arteries; pacemakers and implantable defibrillators that regulate abnormal heart rhythms; catheters, enabling less invasive procedures such as angioplasty; and artificial heart valves for the replacement of damaged heart valves. The invention of these devices has greatly advanced cardiac care, reducing recovery time and complications while improving outcomes in patients. As cardiovascular diseases remain a leading cause of death worldwide, these devices are vital in saving lives and enhancing the quality of life for patients.

Increasing Prevalence of Cardiovascular Diseases

Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. The increasing incidence of cardiovascular diseases, especially coronary artery disease, arrhythmias, and heart valve disorders, is the primary catalyst for the cardiovascular surgical devices market. Rising sedentary lifestyles, poor dietary habits, and increased rates of obesity and diabetes have made CVD cases increase everywhere. This has increased the need for surgical procedures including bypass surgery and valve repair, where advanced devices are more than necessary. Governments and the healthcare sector are also targeting CVD management, which enhances the use of cardiovascular surgical devices to improve patient results and reduce mortality from diseases related to heart conditions. Cardiovascular diseases remain to impact more than half a billion globally. These diseases have resulted in the death of 20.5 million people in 2021, accounting for almost one-third of the total death cases reported worldwide. The previously estimated death cases attributed to cardiovascular diseases stood at 121 million.

Advancements in Surgical Technology

Innovations in surgical technologies are constantly advancing and have thus elevated the cardiovascular surgical devices market by a wide margin. Minimally invasive techniques, such as robotic-assisted surgeries and catheter-based procedures, have come into favor because they reduce the recovery time and complications arising from the procedure. Advanced products include bioresorbable stents, 3D-printed heart valves, and next-generation pacemakers, all of which provide better precision and patient-friendliness. This is pushing demand among healthcare providers, who want to make surgical practice more efficient and outcomes better. Further emphasis for market growth is provided by the introduction of AI and machine learning into cardiovascular diagnostics and surgery planning. In October 2024, Royal Philips will introduce its latest cardiology solutions at the Transcatheter Cardiovascular Therapeutics (TCT).   Innovations are focused on bolstering clinical confidence, improving procedural efficiency, and enhancing patient outcomes in interventional procedures, all of which should bring better care to more people.

Increased Geriatric Population

Another important growth driver of the cardiovascular surgical devices market is the increasing population worldwide with age. Cardiovascular diseases are more prone to develop in the aging population because of the age-related changes that occur in heart function and vascular health. As the life expectancy increases worldwide, the need for surgical interventions with advanced devices is expected to grow. Healthcare systems are focusing on developing specialized cardiac care units and equipping them with state-of-the-art surgical devices to cater to the growing elderly population. This demographic shift creates a sustained demand for cardiovascular surgical devices, ensuring market expansion over the coming years. In 2024, the world's population aged 65 and above will be 10.3%, almost double the share of 5.5% in 1974. It is estimated that the population aged 80 and older will triple in the same period.

Challenges in Cardiovascular Surgical Devices Market

High cost of devices and procedures

One of the main barriers in the cardiovascular surgical devices market is the high cost related to the advanced surgical devices and procedures. Advanced technologies, including bioengineered implants and robotic-assisted systems, are expensive for healthcare providers and patients due to their high cost of investment. The cost is further multiplied by post-operative care and maintenance of specialized equipment. In most developing countries, the lack of healthcare budgets and poor insurance coverage worsens the accessibility issue. This financial burden is limiting the adoption of advanced devices, which hampers the growth of the market in countries with economic constraints and limited healthcare infrastructure.

Stringent Regulatory Requirements

The cardiovascular surgical devices market is also confronted by stringent regulatory requirements and extended approval processes. The safety and efficacy standards set by the regulatory bodies, such as the FDA and EMA, make it difficult for devices to enter the market and may add to the development costs. Manufacturers often face difficulties navigating complex compliance procedures, leading to slowed innovation and limited product availability. Additionally, inconsistent regulations across regions add complexity, creating barriers to global market expansion. These regulatory hurdles affect device manufacturers and restrict healthcare providers’ ability to access the latest technologies promptly.

Cardiac Perfusion Disposables Surgery Device Market

Perfusion disposables claim a substantial share of the cardiac surgery device market. This is because they play a crucial role in maintaining the best blood flow in cardiac strategies. Perfusion disposables, such as oxygenators and tubing sets, form an essential part of the extracorporeal flow structures, which are an integral component of heart surgeries, including bypass strategies. The growing incidence of cardiovascular diseases requires an uninterrupted supply of these disposable products, thereby making perfusion disposables one of the extensive segments in the cardiac surgery device market, considering their indispensable role in supporting successful and safe cardiac surgeries.

Coronary Heart Disease Surgery Device Market

Coronary Heart Disease is one of the most prominent cardiac surgery device market segments.

This is attributed to its huge incidence and the resulting demand for interventions. With CHD being a major cause of death globally, there is an excessive demand for surgical interventions such as CABG and angioplasty. In turn, this may result in an ongoing demand for advanced cardiac surgical treatment devices, including stents, catheters, and grafts, to effectively manage and treat CHD, thereby making it a vital cardiac surgery device market segment. Hospitals Cardiovascular Surgical Devices Market Hospitals could emerge as pivotal players in the global cardiac surgery device market. This is because they are the primary centers for diagnosing and treating cardiovascular illnesses. With a surge in demand for cardiac surgical procedures, hospitals require an extensive selection of advanced surgical devices to efficiently cater to sufferers' desires. Their continuous investments in current technology and devices, in addition, solidify their position as leading cardiac surgical procedure tool market contributors.

Cardiovascular Surgical Devices Market Overview by Regions

 United States Cardiac Surgery Device Market

The United States dominated the cardiac surgery device market. The demand is expected to increase as the prevalence of cardiovascular sicknesses, particularly by rising rates of weight problems, increases. A significant portion of the population undergoes cardiac surgical operations, which fuels the need for superior surgical devices. Furthermore, factors like increasing healthcare costs and the staggering prevalence of heart diseases are the most common cause of deaths among genders and racial groups in the United States, which also contributes to the growth of the cardiac surgery device market. The Centers for Disease Control and Prevention reported that heart disease deaths within the United States were close to 697,000.

France Cardiovascular Surgical Devices Market

The cardiovascular surgical devices market in France is one of the significant segments in the European healthcare industry, driven by the country's advanced medical infrastructure and focus on innovation. The rising prevalence of cardiovascular diseases, coupled with an aging population, has increased the demand for surgical interventions. France's focus on minimally invasive procedures and adopting cutting-edge technologies, such as robotic-assisted surgeries and bioresorbable stents, supports market growth. Government initiatives for enhancing cardiac health care and investments in the field of research and development create an opportunity for the market. The country faces challenges concerning the high costs of devices, along with strict regulatory rules that challenge manufacturers and the health care providers. December 2023, Synthetic organ developer CARMAT confirmed it would be opening a new production facility in Bois-d'Arcy, France.

India Cardiovascular Surgical Devices Market

India's cardiovascular surgical devices market is growing at a fast pace, with the increasing prevalence of cardiovascular diseases, an aging population, and growing awareness about healthcare. The growth of medical infrastructure and the acceptance of innovative technologies, including minimally invasive surgical devices and stents, expands the market. India's low-cost healthcare services attract patients from all over the world, and this boosts the demand for cardiovascular procedures. Government initiatives to elevate cardiac care and a jump in medical tourism further drive demand. However, the lack of access to modern devices from rural areas and affordability issues severely limit adoption. In December 2023, Terumo India launched the Ultimate Nagomi-a drug eluting stent for the cure of coronary artery disease. Its design allows use in both small and large coronary arteries, making it suitable for tailored stent selection to a wider number of patients.

Saudi Arabia Cardiovascular Surgical Devices Market

The cardiovascular surgical devices market in Saudi Arabia is growing steadily, which is driven by an increase in the prevalence of cardiovascular diseases due to lifestyle changes, obesity, and diabetes. The government, under Vision 2030, has been focusing on developing the healthcare infrastructure. So, this has led to investing a lot in advanced medical technologies and cardiac care facilities. There is also an increased awareness about the early diagnosis and treatment of heart diseases that have increased the demand for surgical interventions. The market is also being supported by Saudi Arabia's adoption of minimally invasive procedures and advanced devices. However, the high cost of the device and dependency on import continue to hinder wider market access. May 2024: in partnership with Huma Therapeutics Limited, Bayer released its new heart health screening product in Saudi Arabia.

Major Players Cardiovascular Surgical Devices Market

The Cardiovascular Surgical Devices Market consists of companies such as Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences, Cardinal Health Inc., Medtronic PLC, GE Healthcare, LivaNova PLC, and Terumo Corporation.

Cardiovascular Surgical Devices Market Segments

Product Type 

• Beating Heart Surgery Systems
• Cardiopulmonary Bypass Equipment
• Cardiac Ablation Devices
• Perfusion Disposable

Application

• Congenital Heart Defects
• Cardiac Arrhythmia
• Coronary Heart Disease
• Congestive Heart Failure
• Others

End-User 

• Hospitals
• Ambulatory Surgical Centers
• Others

Regional Market Insights

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherland
• Turkey

Asia Pacific

• China
• Japan
• India
• South Korea
• Thailand
• Malaysia
• Indonesia
• Australia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• Saudi Arabia
• UAE
• South Africa

All the Key players have been covered

•    Overview
•    Recent Development
•    Revenue Analysis

Competitive Landscape and Key Players

• Abbott Laboratories
• Boston Scientific Corporation
• Edwards Lifesciences
• Cardinal Health Inc.
• Medtronic PLC
• GE Healthcare
• LivaNova PLC
• Terumo Corporation

Report Details: